Chlorpromazine Tablets Recalled Due to Packaging Contamination
Amerisource Health Services is recalling specific lots of Chlorpromazine Hydrochloride 25mg tablets nationwide due to detection of a micro-organism in packaging material at the manufacturing site.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The contamination is confined to packaging material only; no micro-organism was detected on the tablets themselves, indicating a precautionary, low-risk recall.
Plain-English summary
Amerisource Health Services LLC is recalling specific lots of Chlorpromazine Hydrochloride Tablets, USP 25mg distributed nationwide. A micro-organism was detected in a specific lot of auxiliary polyester coil used in product packaging at the manufacturing site.
The recall affects 2,708 cartons with expiration dates from August 2026 through December 2026.
The contamination was found only in the packaging material. No micro-organism was detected on any of the tablets themselves.
Healthcare providers and patients with affected lot numbers should contact their healthcare provider or pharmacist with questions about their medication.
The recalled product
- Product
- CHLORPROMAZINE HYDROCHLORIDE (CHLORPROMAZINE HYDROCHLORIDE)
- Brand
- CHLORPROMAZINE HYDROCHLORIDE
- Manufacturer
- Amerisource Health Services LLC
- Category
- Drug
- Hazard
- foreign-substance
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot: a)1020919
- 1021133
- Exp 09/30/2026
- 1021447
- Exp 10/31/2026
- 1021741
- 1022202
- Exp 11/30/2026
- 1022474
- Exp 12/31/2026 Lot: b) 1020460
- exp 08/31/2026
- 1022417
- exp 12/31/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CHLORPROMAZINE HYDROCHLORIDE
- HighChlorpromazine Hydrochloride Tablets recalled for N-nitroso impurity
FDA (Drugs) · 2025-10-15
- HighChlorpromazine Hydrochloride Tablets Recalled for Elevated N-Nitroso Impurity
FDA (Drugs) · 2025-10-15
- HighChlorpromazine Hydrochloride 25 mg Tablets Recalled for Chemical Impurity
FDA (Drugs) · 2025-10-15
- HighPrescription drug recall: Chlorpromazine hydrochloride tablets due to nitrosamine impurity
FDA (Drugs) · 2025-10-15
- HighChlorpromazine Hydrochloride Tablets Recalled for Manufacturing Deviation
FDA (Drugs) · 2025-10-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27